An observational study in Hypertension, Blood Pressure and Home Blood Pressure Measurement, sponsored by DongGuk University. Active, not recruiting at 1 site in Korea, Republic of. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2021-07-12.
Sponsored by DongGuk University · Observational
Home blood pressure measurement has been reported to be associated with better clinic blood pressure and daytime blood pressure control. However, no study has evaluated the association between home blood pressure measurement and control of 24-hour ambulatory blood pressure in real world practice.
The purpose of the present study is to investigate the effect of home blood pressure measurement on the control of ambulatory blood pressure in the real world.
The detailed purposes of the present study are (1) to investigate the effects of home blood pressure measurement on the appropriate control of 24-hour ambulatory blood pressure in hypertensive patients treated with antihypertensive drug, (2) to evaluate the effect of home blood pressure measurement on the occurrence of cardiovascular events and target organ damage, (3) to investigate the status and appropriateness of home blood pressure measurement in the real world, and (4) to investigate factors of home blood pressure measurement methods affecting the treatment of hypertension.
6,114 studies on the registry are indexed under Hypertension; 912 are open to participants now.
This study's enrollment of 701 is above the median of 350 across 1,163 observational studies indexed under Hypertension.
Browse Hypertension studies →DongGuk University is the lead sponsor of 27 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with hypertension who were taking antihypertensive drugs for more than 1 year for treatment of hypertension are recruited through advertising in Goyang City where the hospital is located and Paju City near to the hospital.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
NYHA class (heart failure)
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Difference of 24-hour blood pressure control rate
difference of 24-hour blood pressure control rate between patients who measure and do not measure home blood pressure
Time frame: at baseline and 3 years of follow up
Difference of daytime blood pressure control rate
Difference of daytime blood pressure control rate between patients who measure and do not measure home blood pressure
Time frame: at baseline and 3 years of follow up
Difference of office blood pressure control rate
Difference of office blood pressure control rate between patients who measure and do not measure home blood pressure
Time frame: at baseline and 3 years of follow up
Difference of systolic and diastolic blood pressure (office, 24-hour, daytime, nighttime)
Difference of systolic and diastolic blood pressure (office, 24-hour, daytime, nighttime) between patients who measure and do not measure home blood pressure
Time frame: at baseline and 3 years of follow up
Rate of home blood pressure measurement
Rate of home blood pressure measurement in study population
Time frame: at baseline and 3 years of follow up
Reflection of home blood pressure
Rate of reflecting home blood pressure in the treatment of hypertension at office
Time frame: at baseline and 3 years of follow up
cardiovascular disease prevalence and target organ damage
Difference of cardiovascular disease prevalence and target organ damage between patient who do or do not measure home blood pressure * Composites of cardiovascular disease: number of participants with non-fatal myocardial infarction, angina pectoris, revascularization of arteries, stroke, transient ischemic attack, atrial fibrillation, heart failure hospitalization, progression to end-stage renal failure or elevation of creatinine more than 2-fold, other undefined cardiovascular events at the discretion of the investigator * Target organ damage: left ventricular hypertrophy by electrocardiography, brachial-ankle pulse wave velocity, microalbuminuria
Time frame: at baseline and 3 years of follow up
Changes of home blood pressure measurement rate
Changes of home blood pressure measurement rate in study population after 3 year of follow up from baseline
Time frame: from baseline to 3 years of follow up
Cardiovascular disease events and target organ damage
Difference of occurrence of cardiovascular disease events and target organ damage between patient who measure and do not measure home blood pressure * Composites of cardiovascular disease events: number of participants with first occurrence of non-fatal myocardial infarction, angina pectoris, revascularization of arteries, stroke, transient ischemic attack, atrial fibrillation, heart failure hospitalization, progression to end-stage renal failure or elevation of creatinine more than 2-fold, other undefined cardiovascular events at the discretion of the investigator * Target organ damage: left ventricular hypertrophy by electrocardiography, brachial-ankle pulse wave velocity, microalbuminuria from enrollment
Time frame: during 3 years of follow up from baseline measurement
Plan to share: No — In order to share the IPD, the informed consent from the research participants is required un the Korean law, and the investigators did not get the consent to share at the beginning of this study.
No publications or documents are linked to this record.
Ran from Aug 2018 to primary completion in May 2020, 21 months.
Of 345 non-industry observational studies under Hypertension, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 111. This study's 21 months is below that.
Counting every sponsor, half of 426 studies reached it within 38 months; a quarter within 17 and three quarters within 96.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
DongGuk University